Arai, T.; Hirose, M.; Kagawa, T.; Takeuchi, N.; Kobayashi, T.; Inoue, Y.; Matsuda, Y.
Effectiveness of a 5-Hydroxytryptamine Type 3 Receptor Antagonist for Treating Nintedanib-Induced Diarrhea: A Prospective Observational Study. J. Clin. Med. 2025, 14, 7914.
https://doi.org/10.3390/jcm14227914
AMA Style
Arai T, Hirose M, Kagawa T, Takeuchi N, Kobayashi T, Inoue Y, Matsuda Y.
Effectiveness of a 5-Hydroxytryptamine Type 3 Receptor Antagonist for Treating Nintedanib-Induced Diarrhea: A Prospective Observational Study. Journal of Clinical Medicine. 2025; 14(22):7914.
https://doi.org/10.3390/jcm14227914
Chicago/Turabian Style
Arai, Toru, Masaki Hirose, Tomoko Kagawa, Naoko Takeuchi, Takehiko Kobayashi, Yoshikazu Inoue, and Yoshinobu Matsuda.
2025. "Effectiveness of a 5-Hydroxytryptamine Type 3 Receptor Antagonist for Treating Nintedanib-Induced Diarrhea: A Prospective Observational Study" Journal of Clinical Medicine 14, no. 22: 7914.
https://doi.org/10.3390/jcm14227914
APA Style
Arai, T., Hirose, M., Kagawa, T., Takeuchi, N., Kobayashi, T., Inoue, Y., & Matsuda, Y.
(2025). Effectiveness of a 5-Hydroxytryptamine Type 3 Receptor Antagonist for Treating Nintedanib-Induced Diarrhea: A Prospective Observational Study. Journal of Clinical Medicine, 14(22), 7914.
https://doi.org/10.3390/jcm14227914
